Welcome to FLUotech biosciences
In Pursuit of Better Health Solutions
FluoTech Biosciences is at the forefront of developing advanced therapeutic solutions for cardiovascular diseases, particularly atherosclerosis. Our proprietary FTB-728 nanoparticle platform offers unparalleled drug-loading capacity and precise targeting, revolutionizing how we approach disease treatment.
Our Company
Fast Growing Bio-Tech Company
FluoTech Biosciences is a rapidly expanding biotechnology company dedicated to transforming healthcare through cutting-edge nanomaterial technologies. Founded in April 2024, we have established robust partnerships with leading institutions and secured funding from HKTECH300, Hong Kong’s premier technology startup program.
At FluoTech, we’re revolutionizing cardiovascular treatment with our FTB-728 platform — combining innovation, precision, and sustainability to fight atherosclerosis and empower researchers globally.
Mohamed el. hilal
Founder, CEO of Fluotech Biosciences Limited
Our Values
Driven by Discovery. United in Purpose.
01.
Innovation
We continuously push the boundaries of science to develop groundbreaking solutions.
02.
Teamwork
Together, we achieve more by leveraging the expertise of our team and partners.
03.
Sustainable
We are committed to sustainable practices in all aspects of our operations, ensuring minimal environmental impact.
04.
Integrity
Transparency and honesty guide our interactions with stakeholders, partners, and the community.
05.
Excellence
We strive for excellence in every aspect of our work, from research and development to commercialization.
06.
Commitment
We are deeply committed to improving global health and advancing scientific discovery.
Our Products
Committed to Quality
At FluoTech Biosciences, quality is at the heart of everything we do. We are dedicated to delivering safe, effective, and reliable nanomaterial solutions that meet the highest industry standards.
Clinical Development
Targeted drug delivery with FTB-728 for precise, effective therapies.
Regulatory & Access
Navigating global standards to ensure compliance and accelerate patient access.
Biotech
Transforming cardiovascular treatment through advanced nanotechnology solutions.
Functional Service
Supporting research and clinical applications with reliable, scalable services.
Our Purpose
We are committed to excellence and development of cutting-edge solutions.
FluoTech Biosciences is dedicated to transforming cardiovascular health through innovative nanomaterial solutions. Our mission is to address critical global health challenges.
At FluoTech, we are committed to delivering breakthrough technologies like our proprietary FTB-728 nanoparticle platform, which offers unparalleled drug-loading capacity and precise targeting capabilities as well as ATHRICINE. This dual-purpose technology serves both as a research tool and a therapeutic solution.
Our Collaborations
